High rate of Exophiala dermatitidis recovery in the airways of patients with cystic fibrosis is associated with pancreatic insufficiency

Journal of Clinical Microbiology

Volumn 49, Issue 3, 2011, Pages 1004-1009

  Kondori, Nahid ^a   Gilljam, Marita ^a   Lindblad, Anders ^a   Jönsson, Bodil ^a   Moore, Edward R B ^b   Wennerås, Christine ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; CASPOFUNGIN; FLUCYTOSINE; ITRACONAZOLE; POSACONAZOLE; VORICONAZOLE;

ADOLESCENT; ADULT; AGED; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; EXOPHIALA; EXOPHIALA DERMATITIDIS; FEMALE; FUNGAL COLONIZATION; FUNGUS ISOLATION; GRAFT RECIPIENT; HUMAN; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PANCREAS INSUFFICIENCY; PRIORITY JOURNAL; SPUTUM ANALYSIS; SWEDEN;

ADOLESCENT; ADULT; AGED; ANTIFUNGAL AGENTS; BRONCHOALVEOLAR LAVAGE FLUID; CARRIER STATE; CYSTIC FIBROSIS; EXOCRINE PANCREATIC INSUFFICIENCY; EXOPHIALA; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MYCOSES; PREVALENCE; RESPIRATORY TRACT INFECTIONS; SPUTUM; SWEDEN; YOUNG ADULT;

EXOPHIALA; EXOPHIALA DERMATITIDIS; FUNGI;

EID: 79952355954     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01899-10     Document Type: Article

References (26)

1. Aoyama, Y., M. Nomura, S. Yamanaka, Y. Ogawa, and Y. Kitajima. 2009. Subcutaneous phaeohyphomycosis caused by Exophiala xenobiotica in a non-Hodgkin lymphoma patient. Med. Mycol. 47:95-99.
2. Bakare, N., V. Rickerts, J. Bargon, and G. Just-Nubling. 2003. Prevalence of Aspergillus fumigatus and other fungal species in the sputum of adult patients with cystic fibrosis. Mycoses 46:19-23.
3. Carvalho, A., et al. 2007. Multiplex PCR identification of eight clinically relevant Candida species. Med. Mycol. 45:619-627. (Pubitemid 350176712)
4. Chang, X., R. Li, J. Yu, X. Bao, and J. Qin. 2009. Phaeohyphomycosis of the central nervous system caused by Exophiala dermatitidis in a 3-year-old immunocompetent host. J. Child Neurol. 24:342-345.
5. Cochrane, G. R., and M. Y. Galperin. 2010. The 2010 Nucleic acids research database issue and online database collection: a community of data resources. Nucleic Acids Res. 38:D1-D4.
6. Collaco, J. M., and G. R. Cutting. 2008. Update on gene modifiers in cystic fibrosis. Curr. Opin. Pulm. Med. 14:559-566.
7. De Hoog, G. S., J. Guarro, J. Gene, and M. J. Figueras. 2001. Atlas of clinical fungi, 2 ed. ASM Press, Washington, DC.
8. Diemert, D., D. Kunimoto, C. Sand, and R. Rennie. 2001. Sputum isolation of Wangiella dermatitidis in patients with cystic fibrosis. Scand. J. Infect. Dis. 33:777-779.
9. Farrell, P. M. 2008. The prevalence of cystic fibrosis in the European Union. J. Cyst. Fibros. 7:450-453.
10. Fuller, J., et al. 2010. Caspofungin Etest endpoint for Aspergillus isolates shows poor agreement with the reference minimum effective concentration. J. Clin. Microbiol. 48:479-482.
11. Haase, G., H. Skopnik, T. Groten, G. Kusenbach, and H. G. Posselt. 1991. Long-term fungal culture of sputum from patients with cystic fibrosis. Mycoses 34(Suppl. 1):49-52.
12. Haase, G., H. Skopnik, and G. Kusenbach. 1990. Exophiala dermatitidis infection in cystic fibrosis. Lancet 336:188-189.
13. Horré, R., et al. 2004. Isolation of fungi, especially Exophiala dermatitidis, in patients suffering from cystic fibrosis. A prospective study. Respiration 71: 360-366.
14. Johnson, E. M., A. Szekely, and D. W. Warnock. 1998. In-vitro activity of voriconazole, itraconazole and amphotericin B against filamentous fungi. J. Antimicrob. Chemother. 42:741-745.
15. Kenney, R. T., et al. 1992. Successful treatment of systemic Exophiala dermatitidis infection in a patient with chronic granulomatous disease. Clin. Infect. Dis. 14:235-242.
16. Kerr, J. R., et al. 1999. Pseudomonas aeruginosa pyocyanin and 1-hydroxyphenazine inhibit fungal growth. J. Clin. Pathol. 52:385-387.
17. Kusenbach, G., H. Skopnik, G. Haase, F. Friedrichs, and H. Dohmen. 1992. Exophiala dermatitidis pneumonia in cystic fibrosis. Eur. J. Pediatr. 151:344-346.
18. Li, D. M., and G. S. de Hoog. 2009. Cerebral phaeohyphomycosis - a cure at what lengths? Lancet Infect. Dis. 9:376-383.
19. Millar, F. A., N. J. Simmonds, and M. E. Hodson. 2009. Trends in pathogens colonising the respiratory tract of adult patients with cystic fibrosis, 1985-2005. J. Cyst Fibros. 8:386-391.
20. Pihet, M., et al. 2009. Occurrence and relevance of filamentous fungi in respiratory secretions of patients with cystic fibrosis - a review. Med. Mycol. 47:387-397.
21. Ramette, A. 2007. Multivariate analyses in microbial ecology. FEMS Microbiol. Ecol. 62:142-160.
22. Rivard, R. G., et al. 2007. Efficacy of caspofungin and posaconazole in a murine model of disseminated Exophiala infection. Med. Mycol. 45:685-689. (Pubitemid 350153960)
23. Skovbjerg, S., et al. 2009. Optimization of the detection of microbes in blood from immunocompromised patients with haematological malignancies. Clin. Microbiol. Infect. 15:680-683.
24. Szekely, A., E. M. Johnson, and D. W. Warnock. 1999. Comparison of E-test and broth microdilution methods for antifungal drug susceptibility testing of molds. J. Clin. Microbiol. 37:1480-1483.
25. Tolstoi, L. G., and C. L. Smith. 1999. Human Genome Project and cystic fibrosis - a symbiotic relationship. J. Am. Diet Assoc. 99:1421-1427.
26. Trost, A., et al. 2004. Identification of clinically relevant yeasts by PCR/RFLP. J. Microbiol. Methods 56:201-211. (Pubitemid 38117179)